Allan Reine
2017 - Pieris Pharmaceuticals
In 2017, Allan Reine earned a total compensation of $2M as Chief Financial Officer at Pieris Pharmaceuticals.
Compensation breakdown
| Bonus | $150,000 |
|---|---|
| Option Awards | $1,662,130 |
| Salary | $148,352 |
| Total | $1,960,482 |
Reine received $1.7M in option awards, accounting for 85% of the total pay in 2017.
Reine also received $150K in bonus and $148.4K in salary.
Rankings
In 2017, Allan Reine's compensation ranked 5,598th out of 14,666 executives tracked by ExecPay. In other words, Reine earned more than 61.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,598 out of 14,666 | 62nd |
Division Manufacturing | 2,025 out of 5,772 | 65th |
Major group Chemicals And Allied Products | 625 out of 2,075 | 70th |
Industry group Drugs | 481 out of 1,731 | 72nd |
Industry Pharmaceutical Preparations | 377 out of 1,333 | 72nd |
Source: SEC filing on June 14, 2018.
Reine's colleagues
We found three more compensation records of executives who worked with Allan Reine at Pieris Pharmaceuticals in 2017.